» Articles » PMID: 30881419

Effects of Lymph Node Metastasis of Thoracic Esophageal Squamous Cell Carcinoma on Design of Radiotherapy Target Volume

Overview
Journal Pak J Med Sci
Specialty General Medicine
Date 2019 Mar 19
PMID 30881419
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To analyze the correlation between lymph node metastasis of thoracic esophageal squamous cell carcinoma (ESCC) and clinical and pathological factors, and to provide a reference for the outline of clinical target volume.

Methods: The pathological characteristics of 1034 thoracic ESCC patients after surgery were described, and the correlations between clinical and pathological factors and lymph node metastasis were studied by univariate and Logistic multivariate analyses.

Results: Lymph node metastasis was significantly correlated with tumor length, invasion depth and differentiation degree (P<0.01), but not gender, age, tumor site or pathological type (P>0.05). Logistic multivariate analysis showed that tumor length, invasion depth and differentiation degree were independent risk factors for thoracic ESCC. The lymph node metastasis rates of mid-thoracic ESCC in the middle mediastinum, lower-thoracic ESCC in the lower mediastinum and abdominal cavity were 18.5%, 35.3% and 19.7% respectively in the T1-T2 stage. In the T3-T4 stage, the lymph node metastasis rates of mid-thoracic ESCC in the middle mediastinum and abdominal cavity were 39.6% and 17.4% respectively, and those of lower-thoracic ESCC in middle and lower mediastina and abdominal cavity were 21.1%, 43.4% and 29.8% respectively. Highly/moderately differentiated mid-thoracic ESCC in the middle mediastinum, lower-thoracic ESCC in middle and lower mediastina and abdominal cavity had the lymph node metastasis rates of 34.7%, 15.1%, 33.5% and 23.7% respectively. Lowly differentiated mid-thoracic ESCC in the middle mediastinum and abdominal cavity had the lymph node metastasis rates of 46.9% a 29.6% respectively, and those of lower-thoracic ESCC in middle and lower mediastina and abdominal cavity were 25.5%, 49.1% and 27.3% respectively.

Conclusion: During the outline of radiotherapy target volume for thoracic ESCC, tumor length, invasion depth and differentiation degree should be comprehensively considered to selectively irradiate the regions prone to lymph node metastasis.

Citing Articles

Lymph node metastases status in esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapy: a single-center cross-sectional study.

Nguyen A, Pham V, Tran M, Nguyen P Transl Gastroenterol Hepatol. 2025; 10:8.

PMID: 39944591 PMC: 11811556. DOI: 10.21037/tgh-24-76.


Effects of psychological support intervention on patients with nasopharyngeal carcinoma undergoing radiotherapy.

Wang C, Liu X, Li Y, Liu D, Yang L, Wang Y Pak J Med Sci. 2024; 40(7):1420-1424.

PMID: 39092052 PMC: 11255788. DOI: 10.12669/pjms.40.7.7875.


Diagnostic value of contrast-enhanced ultrasound combined with MRI for cervical hyperplastic, tuberculosis-infected, and metastatic lymph nodes.

Yu X, Zhang W, He N, Su D, Zhao Y Pak J Med Sci. 2023; 39(4):950-955.

PMID: 37492335 PMC: 10364260. DOI: 10.12669/pjms.39.4.7572.

References
1.
Cooper J, Guo M, Herskovic A, Macdonald J, Martenson Jr J, Al-Sarraf M . Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA. 1999; 281(17):1623-7. DOI: 10.1001/jama.281.17.1623. View

2.
Minsky B, Pajak T, Ginsberg R, Pisansky T, Martenson J, Komaki R . INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol. 2002; 20(5):1167-74. DOI: 10.1200/JCO.2002.20.5.1167. View

3.
Bedenne L, Michel P, Bouche O, Milan C, Mariette C, Conroy T . Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol. 2007; 25(10):1160-8. DOI: 10.1200/JCO.2005.04.7118. View

4.
Ding X, Zhang J, Li B, Wang Z, Huang W, Zhou T . A meta-analysis of lymph node metastasis rate for patients with thoracic oesophageal cancer and its implication in delineation of clinical target volume for radiation therapy. Br J Radiol. 2012; 85(1019):e1110-9. PMC: 3500810. DOI: 10.1259/bjr/12500248. View

5.
Liu S, Qin X, Zhao B, Qi B, Yao W, Wang T . Differential expression of miRNAs in esophageal cancer tissue. Oncol Lett. 2013; 5(5):1639-1642. PMC: 3678876. DOI: 10.3892/ol.2013.1251. View